Gilead drops 11% after lung cancer drug trial fails, analyst

Gilead drops 11% after lung cancer drug trial fails, analyst says stock is 'overreacting'

Gilead drops 11% after lung cancer drug trial fails, analyst says stock is 'overreacting'

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

California , United States , Merdad Parsey , Gilead Sciences , California Based Gilead , Gilead Chief Medical Officer Merdad , Umer Raffat ,